Caricamento...
Disease-modifying therapy for proteinopathies: Can the exception become the rule?
Disease-modifying therapies for proteinopathies are urgently needed yet clinical trials for the major neurodegenerative diseases, Alzheimer’s and Parkinson’s, have been failing at an alarming rate leaving patients and caregivers scrambling for any sign of hope. At the same time, for one family of pr...
Salvato in:
| Pubblicato in: | Prog Mol Biol Transl Sci |
|---|---|
| Autore principale: | |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2019
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7032046/ https://ncbi.nlm.nih.gov/pubmed/31699321 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/bs.pmbts.2019.07.010 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|